Major Adverse Cardiovascular Events: The Importance of Serum Levels and Haplotypes of the Anti-Inflammatory Cytokine Interleukin 10
Biomolecules · 2024
DOI: 10.3390/biom14080979 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Biomolecules, 2024. Verfasst von Susanne Schulz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Operative Dentistry and Periodontology, Medical Faculty, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Haplotypes, Interleukin-10. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Herzstiftung, HAIN-Diagnostica®, (Germany), HAIN-Diagnostica® (Germany).
Abstract (Originalsprache)
Background
Cardiovascular diseases (CVDs) represent major medical and socio-economic challenges worldwide. There is substantial evidence that CVD is closely linked to inflammatory changes triggered by a complex cytokine network. In this context, interleukin 10 (IL-10) plays an important role as a pleiotropic cytokine with an anti-inflammatory capacity. In this study (a substudy of ClinTrials.gov, identifier: NCT01045070), the prognostic relevance of IL-10 levels and IL-10 haplotypes (rs1800896/rs1800871/rs1800872) was assessed regarding adverse cardiovascular outcomes (combined endpoint: myocardial infarction, stroke/transient ischemic attack, cardiac death and death according to stroke) within a 10-year follow-up. Patients and methods: At baseline, 1002 in-patients with CVD were enrolled. Serum levels of IL-10 were evaluated utilizing flow cytometry (BD™ Cytometric Bead Array). Haplotype analyses were carried out by polymerase chain reactions with sequence-specific primers (PCR-SSP).
Results
In a survival analysis, IL-10 haplotypes were not proven to be cardiovascular prognostic factors in a 10-year follow-up (Breslow test: p = 0.423). However, a higher IL-10 level was associated with adverse cardiovascular outcomes (Breslow test: p = 0.047). A survival analysis considering adjusted hazard ratios (HRs) could not confirm this correlation (Cox regression: adjusted HR = 1.26, p = 0.168).
Conclusion
In the present study, an elevated IL-10 level but not IL-10 haplotypes was linked to adverse cardiovascular outcomes (10-year follow-up) in a cohort of CVD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Operative Dentistry and Periodontology, Medical Faculty, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.
- Center for Medical Basic Research, Medical Faculty, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany.
- Department of Cardiology, Paracelsus-Harz-Clinic Bad Suderode, 06485 Quedlinburg, Germany.
- Department of Medicine III, Medical Faculty, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany.
ORCID-Profile: Susanne Schulz, Axel Schlitt, Stefan Reichert
Förderung
- Deutsche Herzstiftung
- HAIN-Diagnostica®, (Germany)
- HAIN-Diagnostica® (Germany)
Zitieren
APA
Schulz, S., Reuter, L., Navarrete Santos, A., Bitter, K., Rehm, S., Schlitt, A., & Reichert, S. (2024). Major Adverse Cardiovascular Events: The Importance of Serum Levels and Haplotypes of the Anti-Inflammatory Cytokine Interleukin 10. Biomolecules. https://doi.org/10.3390/biom14080979
Vancouver
Schulz S, Reuter L, Navarrete Santos A, Bitter K, Rehm S, Schlitt A, et al. Major Adverse Cardiovascular Events: The Importance of Serum Levels and Haplotypes of the Anti-Inflammatory Cytokine Interleukin 10. Biomolecules. 2024. doi:10.3390/biom14080979
BibTeX
@article{Schulz2024,
author = {Schulz, Susanne and Reuter, Leonie and Navarrete Santos, Alexander and Bitter, Kerstin and Rehm, Selina and Schlitt, Axel and Reichert, Stefan},
title = {Major Adverse Cardiovascular Events: The Importance of Serum Levels and Haplotypes of the Anti-Inflammatory Cytokine Interleukin 10},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14080979}
}
EUVIMED